Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M-A Bigard

Showing results (61-70 of 71) with videos related to

Pageof 8
Sort By:
Alimentary Pharmacology & Therapeutics|March 13, 2010
Infliximab for refractory ulcerative proctitisG Bouguen, X Roblin, A Bourreille, et al.
Italian Journal of Gastroenterology and Hepatology|June 6, 1998
Quality of life during acute and intermittent treatment of gastro-oesophageal reflux disease with omeprazole compared with ranitidine. Results from a multicentre clinical trial. The European Study GroupI Wiklund, K D Bardhan, S Müller-Lissner, et al.
BMJ (Clinical Research Ed.)|February 19, 1999
Symptomatic gastro-oesophageal reflux disease: double blind controlled study of intermittent treatment with omeprazole or ranitidine. The European Study GroupK D Bardhan, S Müller-Lissner, M A Bigard, et al.
Alimentary Pharmacology & Therapeutics|July 29, 2008
Interaction of ribavirin with azathioprine metabolism potentially induces myelosuppressionL Peyrin-Biroulet, J-F Cadranel, J-B Nousbaum, et al.
The European Journal of Surgery. Supplement. : = Acta Chirurgica. Supplement|February 23, 1999
Quality of Life in Reflux and Dyspepsia patients. Psychometric documentation of a new disease-specific questionnaire (QOLRAD)I K Wiklund, O Junghard, E Grace, et al.
Journal of Hepatology|March 1, 1996
Comparison of resection, liver transplantation and transcatheter oily chemoembolization in the treatment of hepatocellular carcinomaJ P Bronowicki, K Boudjema, L Chone, et al.
Pharmacoeconomics|February 8, 2000
Cost effectiveness of omeprazole and ranitidine in intermittent treatment of symptomatic gastro-oesophageal reflux diseaseN O Stålhammar, J Carlsson, R Peacock, et al.
Alimentary Pharmacology & Therapeutics|March 5, 2003
Esomeprazole 20 mg and lansoprazole 15 mg in maintaining healed reflux oesophagitis: Metropole study resultsK Lauritsen, J Devière, M-A Bigard, et al.
Alimentary Pharmacology & Therapeutics|February 4, 2003
Esomeprazole 20 mg and lansoprazole 15 mg in maintaining healed reflux oesophagitis: Metropole study resultsK Lauritsen, J Devière, M-A Bigard, et al.
Alimentary Pharmacology & Therapeutics|August 28, 2009
The efficacy and safety of a third anti-TNF monoclonal antibody in Crohn's disease after failure of two other anti-TNF antibodiesM Allez, S Vermeire, N Mozziconacci, et al.
Pageof 8

Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
Alimentary Pharmacology & Therapeutics|March 13, 2010
Infliximab for refractory ulcerative proctitisG Bouguen, X Roblin, A Bourreille, et al.
Italian Journal of Gastroenterology and Hepatology|June 6, 1998
Quality of life during acute and intermittent treatment of gastro-oesophageal reflux disease with omeprazole compared with ranitidine. Results from a multicentre clinical trial. The European Study GroupI Wiklund, K D Bardhan, S Müller-Lissner, et al.
BMJ (Clinical Research Ed.)|February 19, 1999
Symptomatic gastro-oesophageal reflux disease: double blind controlled study of intermittent treatment with omeprazole or ranitidine. The European Study GroupK D Bardhan, S Müller-Lissner, M A Bigard, et al.
Alimentary Pharmacology & Therapeutics|July 29, 2008
Interaction of ribavirin with azathioprine metabolism potentially induces myelosuppressionL Peyrin-Biroulet, J-F Cadranel, J-B Nousbaum, et al.
The European Journal of Surgery. Supplement. : = Acta Chirurgica. Supplement|February 23, 1999
Quality of Life in Reflux and Dyspepsia patients. Psychometric documentation of a new disease-specific questionnaire (QOLRAD)I K Wiklund, O Junghard, E Grace, et al.
Journal of Hepatology|March 1, 1996
Comparison of resection, liver transplantation and transcatheter oily chemoembolization in the treatment of hepatocellular carcinomaJ P Bronowicki, K Boudjema, L Chone, et al.
Pharmacoeconomics|February 8, 2000
Cost effectiveness of omeprazole and ranitidine in intermittent treatment of symptomatic gastro-oesophageal reflux diseaseN O Stålhammar, J Carlsson, R Peacock, et al.
Alimentary Pharmacology & Therapeutics|March 5, 2003
Esomeprazole 20 mg and lansoprazole 15 mg in maintaining healed reflux oesophagitis: Metropole study resultsK Lauritsen, J Devière, M-A Bigard, et al.
Alimentary Pharmacology & Therapeutics|February 4, 2003
Esomeprazole 20 mg and lansoprazole 15 mg in maintaining healed reflux oesophagitis: Metropole study resultsK Lauritsen, J Devière, M-A Bigard, et al.
Alimentary Pharmacology & Therapeutics|August 28, 2009
The efficacy and safety of a third anti-TNF monoclonal antibody in Crohn's disease after failure of two other anti-TNF antibodiesM Allez, S Vermeire, N Mozziconacci, et al.
Pageof 8